# Baxter Health Enlon Products

Baxter Health Enlon Products is an other based in Deerfield, United States.

## Overview

- **Organization type:** other
- **Headquarters:** Deerfield, United States
- **Region:** North America
- **Address:** Deerfield, United States
- **Assets under management:** Undisclosed
- **Website:** https://baxterproducts.com

## Regulatory record

- **Reports private funds:** No

## About

Baxter Health Enlon Products is a product line within Baxter International, a global healthcare company founded in 1931. Enlon is the brand name for edrophonium chloride, a drug used to reverse the effects of non-depolarizing neuromuscular blocking agents after surgery. This product line is one of many in Baxter's Medication Delivery segment. Strategy is production and distribution of generic injectable drugs for hospital use. Baxter's medication delivery business manufactures over 170 different products, including IV solutions, infusion systems, and anesthesia drugs. Enlon competes in the neuromuscular blockade reversal market alongside products from other generic manufacturers. Distribution reaches US hospitals and healthcare facilities. Baxter International reported 2025 revenue of approximately $14.8 billion globally, but no breakdown is available for the Enlon product line specifically. No distinct team size or leadership is publicly associated with this product line alone. Baxter Health Enlon Products exists as a discrete SKU within a publicly traded global corporation, not as a standalone investment or entity. Its structural differentiator is status as a generic drug product subject to FDA regulation and pricing pressures typical of the hospital pharmaceutical market.

## Sectors

- Healthcare Services
- Medical Devices

## Questions

### What is Enlon used for?

Enlon (edrophonium chloride) is a drug used to reverse the effects of non-depolarizing neuromuscular blocking agents. It is administered by anesthesiologists after surgery to restore normal muscle function in patients who have received muscle relaxants.

### Is Baxter Health Enlon Products a separate company from Baxter International?

No. Baxter Health Enlon Products is a product line within Baxter International, a publicly traded healthcare company. It is not a separate legal entity, family office, or investment vehicle.

### What is the market for neuromuscular blocking reversal agents?

The market includes drugs like neostigmine, sugammadex (Bridion), and edrophonium. Enlon competes primarily with neostigmine and sugammadex in US hospitals. The total US market for such agents is estimated at several hundred million dollars annually.

### Does Baxter Health Enlon Products have any publicly listed AUM or investment strategy?

No. The entity has no AUM or investment operations. It is a commercial product within a larger corporation's regulated drug portfolio.

### How can I find financial data for the Enlon product line?

Baxter International does not publicly disclose product-level revenue for older generic drugs like Enlon. Financial data is aggregated in Baxter's Medication Delivery segment reports, available in SEC filings.

## Related profiles

- [Alamo Group Inc.](https://altss.com/profile/alamo-group-inc)
- [Western Digital Corporation](https://altss.com/profile/western-digital-corporation)

---

Updated: 2026-08-11T02:43:31.692Z

Canonical page: https://altss.com/profile/baxter-health-enlon-products

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology